EoI for Development and Manufacture of Multiple Strengths of C-Mn3O4 NP Nanodrug Formulations and Matching Placebo for Clinical Trial Batches for Neonatal Hyperbilirubinemia and Associated Neurotoxicity or Bilirubin Encephalopathy | Fundizzle
Indian Council of Medical Research
EoI for Development and Manufacture of Multiple Strengths of C-Mn3O4 NP Nanodrug Formulations and Matching Placebo for Clinical Trial Batches for Neonatal Hyperbilirubinemia and Associated Neurotoxicity or Bilirubin Encephalopathy
